1. Home
  2. CPIX vs ANEB Comparison

CPIX vs ANEB Comparison

Compare CPIX & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • ANEB
  • Stock Information
  • Founded
  • CPIX 1999
  • ANEB 2020
  • Country
  • CPIX United States
  • ANEB United States
  • Employees
  • CPIX N/A
  • ANEB N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPIX Health Care
  • ANEB Health Care
  • Exchange
  • CPIX Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • CPIX 51.5M
  • ANEB 111.8M
  • IPO Year
  • CPIX 2009
  • ANEB 2021
  • Fundamental
  • Price
  • CPIX $3.21
  • ANEB $2.64
  • Analyst Decision
  • CPIX
  • ANEB Buy
  • Analyst Count
  • CPIX 0
  • ANEB 2
  • Target Price
  • CPIX N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • CPIX 30.3K
  • ANEB 22.3K
  • Earning Date
  • CPIX 11-04-2025
  • ANEB 11-14-2025
  • Dividend Yield
  • CPIX N/A
  • ANEB N/A
  • EPS Growth
  • CPIX N/A
  • ANEB N/A
  • EPS
  • CPIX N/A
  • ANEB N/A
  • Revenue
  • CPIX $42,071,813.00
  • ANEB N/A
  • Revenue This Year
  • CPIX N/A
  • ANEB N/A
  • Revenue Next Year
  • CPIX N/A
  • ANEB N/A
  • P/E Ratio
  • CPIX N/A
  • ANEB N/A
  • Revenue Growth
  • CPIX 11.34
  • ANEB N/A
  • 52 Week Low
  • CPIX $1.04
  • ANEB $0.80
  • 52 Week High
  • CPIX $7.25
  • ANEB $3.42
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 45.37
  • ANEB 60.42
  • Support Level
  • CPIX $3.41
  • ANEB $2.50
  • Resistance Level
  • CPIX $3.54
  • ANEB $2.76
  • Average True Range (ATR)
  • CPIX 0.19
  • ANEB 0.13
  • MACD
  • CPIX -0.02
  • ANEB 0.02
  • Stochastic Oscillator
  • CPIX 13.77
  • ANEB 76.27

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: